Body composition as a predictor of toxicity after treatment with eribulin for advanced soft tissue sarcoma.
Kobayashi H, Okuma T, Oka H, Okajima K, Ishibashi Y, Zhang L, Hirai T, Ohki T, Tsuda Y, Ikegami M, Sawada R, Shinoda Y, Akiyama T, Kawano H, Goto T, Tanaka S.
Kobayashi H, et al. Among authors: zhang l.
Int J Clin Oncol. 2019 Apr;24(4):437-444. doi: 10.1007/s10147-018-1370-8. Epub 2018 Nov 21.
Int J Clin Oncol. 2019.
PMID: 30465138